UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendations

Supportive care in cancer, 2017-11, Vol.25 (11), p.3295-3304

2017

Volltextzugriff (PDF)

Pre‐fibrotic/early primary myelofibrosis vs. WHO‐defined essential thrombocythemia: The impact of minor clinical diagnostic criteria on the outcome of the disease

American journal of hematology, 2017-09, Vol.92 (9), p.885-891

2017

Volltextzugriff (PDF)

The AST/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine: post hoc analysis of an Austrian multicenter, noninterventional study

Therapeutic advances in medical oncology, 2020, Vol.12, p.1758835919900872-1758835919900872

2020

Volltextzugriff (PDF)

Identification of CD203c as a New Basophil-Specific Flow-Marker in Ph + Chronic Myeloid Leukemia

Cells (Basel, Switzerland), 2022-12, Vol.12 (1), p.3

2022

Volltextzugriff (PDF)

Is ruxolitinib a potentially useful drug in hematological malignancies with RAS pathway hyperactivation?

Haematologica (Roma), 2016-12, Vol.101 (12), p.e492-e492

2016

Volltextzugriff (PDF)

Real World Results of Multiple Myeloma Patients - Low Mortality Rate from First-Line to Second-Line Treatment

Blood, 2022-11, Vol.140 (Supplement 1), p.12598-12599

2022

Volltextzugriff (PDF)

Updated Austrian treatment algorithm for metastatic triple-negative breast cancer

Wiener Klinische Wochenschrift, 2024-06, Vol.136 (11-12), p.347-361

2024

Volltextzugriff (PDF)

DIsCOvER: A multicenter, randomized, double-blind, placebo-controlled, phase III clinical trial to investigate the efficacy and safety of dronabinol in the improvement of chemotherapy-induced and tumor-related symptoms in patients with locally advanced or metastatic pancreas cancer during first-line chemotherapy

Journal of clinical oncology, 2024-01, Vol.42 (3_suppl), p.TPS711-TPS711

2024

Volltextzugriff (PDF)

Comparison of nab-paclitaxel plus gemcitabine in elderly versus younger patients with metastatic pancreatic cancer: Analysis of a multicentre, prospective, non-interventional study

European journal of cancer (1990), 2021-01, Vol.143, p.101-112

2021

Volltextzugriff (PDF)

Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group

Annals of hematology, 2014-11, Vol.93 (11), p.1825-1838

2014

Volltextzugriff (PDF)

Phenotypic characterization of disease‐initiating stem cells in JAK2‐ or CALR‐mutated myeloproliferative neoplasms

American journal of hematology, 2023-05, Vol.98 (5), p.770-783

2023

Volltextzugriff (PDF)

Updated Austrian treatment algorithm in HER2+ metastatic breast cancer

Wiener Klinische Wochenschrift, 2022, Vol.134 (1-2), p.63-72

2022

Volltextzugriff (PDF)

Overexpression of PD-L1 Correlates with JAK2-V617F Mutational Burden and Is Associated with Chromosome 9p Uniparental Disomy in MPN

Blood, 2020-11, Vol.136 (Supplement 1), p.24-24

2020

Volltextzugriff (PDF)

In vitro and in vivo effects of JAK2 inhibition in chronic myelomonocytic leukemia

European journal of haematology, 2016-12, Vol.97 (6), p.562-567

2016

Volltextzugriff (PDF)

Austrian recommendations for the management of essential thrombocythemia

Wiener Klinische Wochenschrift, 2021, Vol.133 (1-2), p.52-61

2021

Volltextzugriff (PDF)

In vitro and in vivo effects of JAK 2 inhibition in chronic myelomonocytic leukemia

European journal of haematology, 2016-12, Vol.97 (6), p.562-567

2016

Volltextzugriff (PDF)

Azacitidine in CMML: Matched-pair analyses of daily-life patients reveal modest effects on clinical course and survival

Leukemia research, 2014-04, Vol.38 (4), p.475-483

2014

Volltextzugriff (PDF)

Leukopenie

Wiener klinische Wochenschrift Education, 2008-10, Vol.3 (3), p.161-178

2008

Volltextzugriff (PDF)

Azacitidine in patients with WHO-defined AML - results of 155 patients from the Austrian Azacitidine Registry of the AGMT-Study Group

Journal of hematology and oncology, 2013-04, Vol.6 (1), p.32-32, Article 32

2013

Volltextzugriff (PDF)

Leukozytose

Wiener klinische Wochenschrift Education, 2008-05, Vol.3 (1), p.35-57

2008

Volltextzugriff (PDF)

The Austrian biodatabase for chronic myelomonocytic leukemia (ABCMML): A representative and useful real-life data source for further biomedical research

Wiener Klinische Wochenschrift, 2019-09, Vol.131 (17-18), p.410-418

2019

Volltextzugriff (PDF)

Intensive Post-Remission Consolidation with G-CSF-Support: Tolerability, Safety, Reduced Hospitalization, and Efficacy of a New Treatment Protocol for AML Patients ≥60 Years

Blood, 2016-12, Vol.128 (22), p.2797-2797

2016

Volltextzugriff (PDF)

Survival in Essential Thrombocythemia and Prefibrotic Primary Myelofibrosis - Correlation of Clinical Phenotype with Histomorphological Diagnosis

Blood, 2016-12, Vol.128 (22), p.1932-1932

2016

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(45)

Publikationsform

Artikel
(49)

Sprache

Englisch
(47)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendations

Pre‐fibrotic/early primary myelofibrosis vs. WHO‐defined essential thrombocythemia: The impact of minor clinical diagnostic criteria on the outcome of the disease

The AST/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine: post hoc analysis of an Austrian multicenter, noninterventional study

Correlation of RAS-Pathway Mutations and Spontaneous Myeloid Colony Growth with Progression and Transformation in Chronic Myelomonocytic Leukemia-A Retrospective Analysis in 337 Patients

Identification of CD203c as a New Basophil-Specific Flow-Marker in Ph + Chronic Myeloid Leukemia

Is ruxolitinib a potentially useful drug in hematological malignancies with RAS pathway hyperactivation?

Real World Results of Multiple Myeloma Patients - Low Mortality Rate from First-Line to Second-Line Treatment

Updated Austrian treatment algorithm for metastatic triple-negative breast cancer

Comparison of nab-paclitaxel plus gemcitabine in elderly versus younger patients with metastatic pancreatic cancer: Analysis of a multicentre, prospective, non-interventional study

Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group

Phenotypic characterization of disease‐initiating stem cells in JAK2‐ or CALR‐mutated myeloproliferative neoplasms

Updated Austrian treatment algorithm in HER2+ metastatic breast cancer

Phenotyping of Disease-Initiating CD34+/CD38─ Stem Cells in BCR-ABL1─ MPN Reveals Expression of Multiple Cytokine Receptors and Resistance-Related Antigens

Overexpression of PD-L1 Correlates with JAK2-V617F Mutational Burden and Is Associated with Chromosome 9p Uniparental Disomy in MPN

In vitro and in vivo effects of JAK2 inhibition in chronic myelomonocytic leukemia

Austrian recommendations for the management of essential thrombocythemia

In vitro and in vivo effects of JAK 2 inhibition in chronic myelomonocytic leukemia

Azacitidine in CMML: Matched-pair analyses of daily-life patients reveal modest effects on clinical course and survival

Leukopenie

Azacitidine in patients with WHO-defined AML - results of 155 patients from the Austrian Azacitidine Registry of the AGMT-Study Group

Leukozytose

The Austrian biodatabase for chronic myelomonocytic leukemia (ABCMML): A representative and useful real-life data source for further biomedical research

Intensive Post-Remission Consolidation with G-CSF-Support: Tolerability, Safety, Reduced Hospitalization, and Efficacy of a New Treatment Protocol for AML Patients ≥60 Years

Survival in Essential Thrombocythemia and Prefibrotic Primary Myelofibrosis - Correlation of Clinical Phenotype with Histomorphological Diagnosis

Suchergebnisse filtern